XML 64 R17.htm IDEA: XBRL DOCUMENT v3.20.1
Fair Value Disclosures
3 Months Ended
Mar. 31, 2020
Fair Value Disclosures [Abstract]  
Fair Value Disclosures Fair Value Disclosures
We determine the fair market values of our assets and liabilities measured at fair value on a recurring and nonrecurring basis using the fair value hierarchy as prescribed in ASC 820. The standard describes three levels of inputs that may be used to measure fair value as provided below.

Level 1
Quoted prices in active markets for identical assets or liabilities.
Level 2
Observable inputs other than Level 1 prices, such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities.
Level 3
Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities. Level 3 assets and liabilities include financial instruments whose value is determined using pricing models, discounted cash flow methodologies, or similar techniques, as well as instruments for which the determination of fair values requires significant management judgment or estimation.
Assets and liabilities measured at fair value are as follows:
 
Fair Value Measurements Using
(in thousands)
Level 1
 
Level 2
 
Level 3
March 31, 2020
 
 
 
 
 
Available-for-sale debt securities:(1)
 
 
 
 
 
Residential mortgage-backed securities
$

 
$
4,688

 
$

Tax-exempt asset-backed securities

 

 
191,474

CRT securities

 

 
8,015

Equity securities(1)(2)
17,368

 
7,239

 

Loans held for sale(3)

 
767,370

 
6,694

Loans held for investment(4)

 

 
121,037

Derivative assets(5)

 
125,913

 

Derivative liabilities(5)

 
126,459

 

Non-qualified deferred compensation plan liabilities(6)
17,668

 

 

 
 
 
 
 
 
December 31, 2019
 
 
 
 
 
Available-for-sale debt securities:(1)
 
 
 
 
 
Residential mortgage-backed securities
$

 
$
5,266

 
$

Tax-exempt asset-backed securities

 

 
197,027

CRT securities

 

 
11,964

Equity securities(1)(2)
18,484

 
7,130

 

Loans held for sale(3)

 
2,564,281

 
7,043

Loans held for investment(4)

 

 
109,585

Derivative assets(5)

 
48,684

 

Derivative liabilities(5)

 
51,310

 

Non-qualified deferred compensation plan liabilities(6)
18,484

 

 


(1)
Securities are measured at fair value on a recurring basis, generally monthly, except for tax-exempt asset-backed securities and CRT securities which are measured quarterly.
(2)
Equity securities consist of Community Reinvestment Act funds and investments related to our non-qualified deferred compensation plan.
(3)
Loans held for sale purchased through our MCA program are measured at fair value on a recurring basis, generally monthly.
(4)
Includes certain collateral-dependent loans held for investment for which a specific allocation of the allowance for credit losses is based upon the fair value of the loan’s underlying collateral. These loans held for investment are measured on a nonrecurring basis, generally annually or more often as warranted by market and economic conditions.
(5)
Derivative assets and liabilities are measured at fair value on a recurring basis, generally quarterly.
(6)
Non-qualified deferred compensation plan liabilities represent the fair value of the obligation to the employee, which generally corresponds to the fair value of the invested assets, and are measured at fair value on a recurring basis, generally monthly.
Level 3 Valuations
The following table presents a reconciliation of the level 3 fair value category measured at fair value on a recurring basis:
 
 
 
 
 
 
 
Net Realized/Unrealized Gains (Losses)
 
 
(in thousands)
Balance at Beginning of Period
 
Purchases / Additions
 
Sales / Reductions
 
Realized
 
Unrealized
 
Balance at End of Period
Three months ended March 31, 2020
 
 
 
 
 
 
 
 
 
 
 
Available-for-sale debt securities:(1)
 
 
 
 
 
 
 
 
 
 
 
Tax-exempt asset-backed securities
$
197,027

 
$

 
$
(4,353
)
 
$

 
$
(1,200
)
 
$
191,474

CRT securities
$
11,964

 
$

 
$

 
$

 
$
(3,949
)
 
$
8,015

Loans held for sale(2)
$
7,043

 
$
213

 
$
(684
)
 
$
28

 
$
94

 
$
6,694

Three months ended March 31, 2019
 
 
 
 
 
 
 
 
 
 
 
Available-for-sale debt securities:(1)
 
 
 
 
 
 
 
 
 
 
 
Tax-exempt asset-backed securities
$
95,804

 
$
92,010

 
$

 
$

 
$
4,030

 
$
191,844

CRT securities
$

 
$
15,044

 
$

 
$
(331
)
 
$
(4,076
)
 
$
10,637

Loans held for sale(2)
$
16,415

 
$

 
$
(3,878
)
 
$
216

 
$
293

 
$
13,046

(1)
Unrealized gains/(losses) on available-for-sale debt securities are recorded in AOCI and all relate to assets held at March 31, 2020. Realized gains/(losses) are recorded in other non-interest income.
(2)
Realized and unrealized gains/(losses) on loans held for sale are recorded in gain/(loss) on sale of loans held for sale.
Tax-exempt asset-backed securities
The fair value of tax-exempt asset-backed securities is based on a discounted cash flow model, which utilizes Level 3, or unobservable, inputs, the most significant of which were a discount rate and weighted-average life. At March 31, 2020, the discount rates utilized ranged from 3.04% to 3.05% and the weighted-average life ranged from 5.5 years to 8.0 years. On a combined amortized cost weighted-average basis a discount rate of 3.05% and weighted-average life of 6.8 years were utilized to determine the fair value of these securities at March 31, 2020. At December 31, 2019, the combined weighted-average discount rate and weighted-average life utilized were 2.99% and 7.0 years, respectively.
CRT securities
The fair value of CRT securities is based on a discounted cash flow model, which utilizes Level 3, or unobservable, inputs, the most significant of which were a discount rate and weighted-average life. At March 31, 2020, the discount rates utilized ranged from 7.35% to 13.74% and the weighted-average life ranged from 6.8 years to 11.4 years. On a combined amortized cost weighted-average basis a discount rate of 9.48% and a weighted-average life of 8.4 years were utilized to determine the fair value of these securities at March 31, 2020. At December 31, 2019, the combined weighted-average discount rate and combined weighted-average life utilized were 4.54% and 9.3 years, respectively.
Loans held for sale
The fair value of loans held for sale using Level 3 inputs include loans that cannot be sold through normal sale channels and thus require significant management judgment or estimation when determining the fair value. The fair value of such loans is generally based upon quoted prices of comparable loans with a liquidity discount applied. At March 31, 2020, the fair value of these loans was calculated using a weighted-average discounted price of 95.0%, compared to 94.1% at December 31, 2019.
Loans held for investment
Certain collateral-dependent loans held for investment are reported at fair value when, based upon an individual evaluation, the specific allocation of the allowance for credit losses that is deducted from the loan's amortized cost is based upon the fair value of the loan's underlying collateral. The $121.0 million fair value of loans held for investment at March 31, 2020 reported above includes loans held for investment with a carrying value of $177.8 million that were reduced by specific allowance allocations totaling $56.8 million based on collateral valuations utilizing Level 3 inputs. The $109.6 million fair value of loans held for investment at December 31, 2019 reported above includes loans with a carrying value of $145.4 million that were reduced by specific allowance allocations totaling $35.8 million based on collateral valuations utilizing Level 3 inputs.
Fair Value of Financial Instruments
GAAP requires disclosure of fair value information about financial instruments, whether or not recognized on the balance sheet, for which it is practical to estimate that value. In cases where quoted market prices are not available, fair values are based
on estimates using present value or other valuation techniques. Those techniques are significantly affected by the assumptions used, including the discount rate and estimates of future cash flows. This disclosure does not and is not intended to represent the fair value of the Company.
A summary of the carrying amounts and estimated fair values of financial instruments is as follows:
 
March 31, 2020
 
December 31, 2019
(in thousands)
Carrying
Amount
 
Estimated
Fair Value
 
Carrying
Amount
 
Estimated
Fair Value
Financial assets:
 
 
 
 
 
 
 
   Level 1 inputs:
 
 
 
 
 
 
 
Cash and cash equivalents
$
9,660,575

 
$
9,660,575

 
$
4,425,583

 
$
4,425,583

Investment securities
17,368

 
17,368

 
18,484

 
18,484

   Level 2 inputs:
 
 
 
 
 
 
 
Investment securities
11,927

 
11,927

 
12,396

 
12,396

Loans held for sale
767,370

 
767,370

 
2,570,091

 
2,570,091

Derivative assets
125,913

 
125,913

 
48,684

 
48,684

   Level 3 inputs:
 
 
 
 
 
 
 
Investment securities
199,489

 
199,489

 
208,991

 
208,991

Loans held for sale
6,694

 
6,694

 
7,043

 
7,043

Loans held for investment, net
24,205,424

 
24,170,104

 
24,451,215

 
24,478,586

Financial liabilities:
 
 
 
 
 
 
 
   Level 2 inputs:
 
 
 
 
 
 
 
Federal funds purchased
289,165

 
289,165

 
132,270

 
132,270

Customer repurchase agreements
6,102

 
6,102

 
9,496

 
9,496

Other borrowings
4,900,000

 
4,900,000

 
2,400,000

 
2,400,000

Subordinated notes
282,219

 
281,793

 
282,129

 
292,302

Trust preferred subordinated debentures
113,406

 
113,406

 
113,406

 
113,406

Derivative liabilities
126,459

 
126,459

 
51,310

 
51,310

   Level 3 inputs:
 
 
 
 
 
 
 
Deposits
27,134,263

 
30,302,466

 
26,478,593

 
29,357,121


The estimated fair value for cash and cash equivalents, variable rate loans and variable rate debt approximates carrying value. The following methods and assumptions were used by the Company in estimating its fair value disclosures for financial instruments:
Investment Securities
Within the investment securities portfolio, we hold equity securities related to our non-qualified deferred compensation plan that are valued using quoted market prices for identical equity securities in an active market, and are classified as Level 1 assets in the fair value hierarchy. The fair value of the remaining equity securities and residential mortgage-backed securities in our investment portfolio are based on prices obtained from independent pricing services that are based on quoted market prices for the same or similar securities, and are characterized as Level 2 assets in the fair value hierarchy. We have obtained documentation from our primary pricing service regarding their processes and controls applicable to pricing investment securities, and on a quarterly basis we independently verify the prices that we receive from the service provider using two additional independent pricing sources. We also hold tax-exempt asset-backed securities and CRT securities that are valued using a discounted cash flow model, which utilizes Level 3 inputs, and are classified as Level 3 assets in the fair value hierarchy.
Loans Held for Sale
Fair value for loans held for sale is derived from quoted market prices for similar loans, in which case they are characterized as Level 2 assets in the fair value hierarchy, or is derived from third party pricing models, in which case they are characterized as Level 3 assets in the fair value hierarchy.
Derivatives
The estimated fair value of interest rate swaps and caps is obtained from independent pricing services based on quoted market prices for similar derivative contracts and these financial instruments are characterized as Level 2 assets and liabilities in the fair value hierarchy. On a quarterly basis, we independently verify the fair value using an additional independent pricing source. Foreign currency forward contracts are valued based upon quoted market prices obtained from independent pricing
services for similar derivative contracts. As such, these financial instruments are characterized as Level 2 assets and liabilities in the fair value hierarchy. The derivative instruments related to the loans held for sale portfolio include loan purchase commitments and forward sales commitments. Loan purchase commitments are valued based upon the fair value of the underlying mortgage loans to be purchased, which is based on observable market data for similar loans. Forward sales commitments are valued based upon quoted market prices from brokers. As such, these loan purchase commitments and forward sales commitments are characterized as Level 2 assets or liabilities in the fair value hierarchy.